Diabetes and Covid-19 Survey
Our Mission
EURADIA’s mission is to improve the lives of people affected by diabetes both now and in the future, through advocacy of diabetes research in Europe at the highest political and societal levels of influence, by improving coordination of European diabetes research and by shaping the allocation of resources for such research through increased awareness.
What is EURADIA
Who we are: EURADIA is an alliance of organisations working for diabetes research including academic and clinical researchers, healthcare professionals and patient groups.
What we do: We provide a platform for all those undertaking research to work together to benefit the wellbeing of people with diabetes.
A Brief History of EURADIA
EURADIA began in 2003 as a collaboration of NGOs and healthcare companies with an interest in supporting and promoting diabetes research in Europe.
This collaboration has grown in number of stakeholders and has a Secretariat based in the UK.
Information Resources with Focus on Diabetes and Covid-19
SURVEY Diabetes Research Funding in Europe: Impact of Covid-19
A Message to Organisations that Fund Research into Diabetes Because of the Covid-19 pandemic there is evidence that some Organisations have been severely impacted
Funding calls and research resources
Funding calls and research resources for diabetes Diabetes UK Applications page for all research grants European Commission – Research and Innovation Horizon 2020 funding calls:
Online resources for diabetes and covid-19
Online sources of information about diabetes and covid-19. Note the list is not exhaustive and suggestions are welcome. Deutsches Zentrum fur Diabetesforschung German Centres for
';
Recent @TheLancetEndo article reveals that beyond excess risk of hospital admission, increased disease severity, and increased mortality, people with #diabetes suffered from increased non-COVID-related mortality due to pandemic-related reductions in care. https://twitter.com/TheLancetEndo/status/1533441727415083008
David Hopkins & Francesco Rubino comment on:
The effect of #COVID-19 on routine diabetes care and #mortality in people with #diabetes https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00162-0/fulltext
#COVID19 #FREE to read
Feedback welcome! Please review and comment on the draft ADA-EASD Management of #Hyperglycemia in #T2D consensus report.
https://professional.diabetes.org/2022EASDconsensus
Final report will be presented at #EASD2022 in Stockholm in September. Don't miss it: http://bit.ly/3wtc1TS
#EFSD welcomes applications for the following #research #funding programme:
EFSD and Lilly European Diabetes Research Programme
This programme will accept applications within any area of basic or clinical diabetes research
http://www.europeandiabetesfoundation.org/workshops/78-european-foundation-study-diabetes-efsd-and-lilly-european-diabetes-research-programme
📣IDF Europe is launching a new publication to highlight key innovative developments in #diabetes care and ways in which the adoption of innovation can be promoted.
➡️Register to the launch webinar on June 16: https://bit.ly/3sSpwvk
➡️More information: https://bit.ly/3wDU0Uf
We support @EmmanuelMacron’s call during his speech at #WHA75 to invest in primary healthcare systems to strengthen #prevention & resilience to health crises while ensuring that skills, education & digital literacy of #HCPs are fit for purpose.
The complications of type 2 #diabetes need more attention in primary care.
Read more about what needs to be looked for, how best to do it and the most effective interventions. #T2D #MedTwitter
👉 https://easd-elearning.org/type-2-diabetes-complications-in-primary-care/
